[Retracted] Evaluation of lncRNA FOXD3-AS1 as a Biomarker for Early-Stage Lung Cancer Diagnosis and Subtype Identification

Table 4

The diagnostic values of lncRNA FOXD3-AS1 in discriminating early-stage lung cancer.

Index	AUC	95% CI		value	Sensitivity	Specificity	Critical value	Yoden index
		Down	Up
SCLC vs. HS	0.906	0.831	0.982	<0.001	73.700	92.000	0.657	3.940
LUAD vs. HS	0.591	0.453	0.729	0.275	100.000	30.000	0.300	2.460
LUSC vs. HS	0.686	0.562	0.809	0.020	100.000	42.000	0.420	2.750
LC vs. HS	0.751	0.658	0.845	<0.001	73.600	66.000	0.396	3.195
SCLC vs. LUAD	0.901	0.802	1.000	<0.001	73.700	100.000	0.737	3.980
SCLC vs. LUSC	0.857	0.730	0.983	<0.001	73.700	100.000	0.737	3.905
LUAD vs. LUSC	0.674	0.489	0.858	0.084	72.200	62.500	0.347	3.240